National Health Investors, Inc.

NHI Real Estate Reit Healthcare Facilities

National Health Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $375.6 million, up 12.1% from fiscal 2024.

Revenue
+33.8%
EPS
+45.6%
Free cash flow
+2,585.5%
Total debt
+13.9%

Quarter to June 2026, against a year earlier

71.11 0.47 −0.66%
Market cap
$3.5B
P/E
20.5×
Fwd P/E
16.5×
Dividend yield
5.20%
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

National Health Investors, Inc. (NHI) EBITDA

Alert me on EBITDA

National Health Investors, Inc.'s EBITDA for fiscal 2025 was $282.0M, up 7.95% from $261.2M in fiscal 2024. Over the twelve months to 30 June 2026 it was $294.7M. Over the past ten years it has ranged from $163.1M (fiscal 2022) to $312.6M (fiscal 2020); the current reading is higher than 82% of that period. EBITDA has risen for 3 consecutive fiscal years. National Health Investors, Inc. ranks 11th of 17 Reit Healthcare Facilities companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $282.0M 7.95%
FY2024 $261.2M 3.72%
FY2023 $251.8M 54.41%
FY2022 $163.1M (25.47%)
FY2021 $218.8M (29.99%)
FY2020 $312.6M 4.25%
FY2019 $299.9M 7.23%
FY2018 $279.6M 3.42%
FY2017 $270.4M 20.54%
FY2016 $224.3M 1.51%

Quarterly newest first

Period EBITDA Change
Jun 2026 $75.6M (2.27%)
Mar 2026 $77.4M 8.79%
Dec 2025 $71.1M 0.69%
Sep 2025 $70.6M (1.38%)
42 more quarters

Against its own ten years

Low $163.1M High $312.6M
Ten-year median $261.2M
Current reading's percentile 82

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on NHI